APNHY (Aspen Pharmacare Holdings) Other Operating Expense: $307 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APNHY Aspen Pharmacare Holdings Ltd APNHY
73 GF Score
Price $8.89
GF Value $10.03
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings Other Operating Expense?

Aspen Pharmacare Holdings APNHY -1.06% 73 Other Operating Expense is $307 Mil as of Dec. 2025. GuruFocus rates APNHY with a GF Score™ of 73/100 and a GF Value™ of $10.03 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Aspen Pharmacare Holdings's Other Operating Expense for the six months ended in Dec. 2025 was $76 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $307 Mil.

Aspen Pharmacare Holdings's quarterly Other Operating Expense increased from Dec. 2024 ($52 Mil) to Jun. 2025 ($230 Mil) but then declined from Jun. 2025 ($230 Mil) to Dec. 2025 ($76 Mil).

Aspen Pharmacare Holdings's annual Other Operating Expense declined from Jun. 2023 ($297 Mil) to Jun. 2024 ($214 Mil) but then increased from Jun. 2024 ($214 Mil) to Jun. 2025 ($283 Mil).

Aspen Pharmacare Holdings Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Aspen Pharmacare Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings Other Operating Expense Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 340.61 327.61 296.72 214.01 283.17

Aspen Pharmacare Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.69 169.84 51.54 230.47 76.46
APNHY
73GF Score
Aspen Pharmacare Holdings Ltd APNHY
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $307 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $307 Mil mean?
Aspen Pharmacare Holdings (APNHY) has a Other Operating Expense of $307 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Aspen Pharmacare Holdings and its competitors.
Is Aspen Pharmacare Holdings' Other Operating Expense too high?
Aspen Pharmacare Holdings' current Other Operating Expense is $307 Mil. Overall, Aspen Pharmacare Holdings has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' Other Operating Expense compare to ZTS and UTHR?
Aspen Pharmacare Holdings' Other Operating Expense of $307 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Aspen Pharmacare Holdings and its competitors. Aspen Pharmacare Holdings's current Other Operating Expense is $307 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (APNHY) is currently considered Modestly Undervalued. The stock's GF Value™ is $10.03, compared to a current price of $8.89 — trading 11.4% below its estimated fair value. The current Other Operating Expense is $307 Mil. Aspen Pharmacare Holdings' overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Aspen Pharmacare Holdings (APNHY), the current Other Operating Expense is $307 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Pharmacare Holdings (APNHY) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of $8.89 is trading 11.4% below its estimated GF Value™ of $10.03. GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.

Key valuation signals for APNHY:

  • Other Operating Expense: $307 Mil
  • GF Value™: $10.03 vs. price of $8.89 (11.4% below fair value)
  • GF Score™: 73/100 with 10 warning signs

No single metric tells the full story. See the APNHY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
73GF Score

Get the complete analysis for APNHY

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.89
Price
$10.03
GF Value